The SUB‐urothelial DUrvalumab InjEction‐1 (SUBDUE‐1) trial: first‐in‐human trial in patients with bladder cancer
Article in BJU International (March 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Article in BJU International (March 2024)
Article in CPT Pharmacometrics & Systems Pharmacology (September 2023)
Book chapter (July 2023)